Axsome Therapeutics, Inc.
Clinical trials sponsored by Axsome Therapeutics, Inc., explained in plain language.
-
Alzheimer's agitation drug safety study halted early
Disease control TerminatedThis study looked at the long-term safety of a drug called AXS-05 for treating agitation in people with Alzheimer's disease. It included 139 participants who had already completed earlier studies. The main goal was to track side effects over time. The study was terminated early, …
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Depression drug trial halted: what happened with AXS-05?
Disease control TerminatedThis study looked at the long-term safety and effectiveness of an experimental drug called AXS-05 for people with major depression that didn't improve with other treatments. About 181 adults who had already tried other antidepressants without success took part. The study was stop…
Phase: PHASE2 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC